Compare BKD & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKD | VCYT |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | N/A | 2013 |
| Metric | BKD | VCYT |
|---|---|---|
| Price | $13.94 | $34.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $15.10 | ★ $44.43 |
| AVG Volume (30 Days) | ★ 3.1M | 741.9K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | N/A |
| Revenue This Year | $0.08 | $13.76 |
| Revenue Next Year | $3.99 | $12.34 |
| P/E Ratio | ★ N/A | $41.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.07 | $22.61 |
| 52 Week High | $17.09 | $50.71 |
| Indicator | BKD | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 48.88 | 56.05 |
| Support Level | $13.30 | $34.13 |
| Resistance Level | $17.09 | $37.24 |
| Average True Range (ATR) | 0.44 | 1.45 |
| MACD | 0.03 | 0.41 |
| Stochastic Oscillator | 63.37 | 84.83 |
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).